Chimeric antigen receptor T-cell therapy — assessment and management of toxicities

Sattva S. Neelapu(The University of Texas MD Anderson Cancer Center), Sudhakar Tummala(The University of Texas MD Anderson Cancer Center), Partow Kebriaei(The University of Texas MD Anderson Cancer Center), William G. Wierda(The University of Texas MD Anderson Cancer Center), Cristina Gutiérrez(The University of Texas MD Anderson Cancer Center), Frederick L. Locke(Moffitt Cancer Center), Krishna V. Komanduri(University of Miami), Yi Lin(Mayo Clinic), Nitin Jain(The University of Texas MD Anderson Cancer Center), Naval Daver(The University of Texas MD Anderson Cancer Center), Jason R. Westin(The University of Texas MD Anderson Cancer Center), Alison Gulbis(The University of Texas MD Anderson Cancer Center), Monica Loghin(The University of Texas MD Anderson Cancer Center), John de Groot(The University of Texas MD Anderson Cancer Center), Sherry Adkins(The University of Texas MD Anderson Cancer Center), Suzanne E. Davis(The University of Texas MD Anderson Cancer Center), Katayoun Rezvani(The University of Texas MD Anderson Cancer Center), Patrick Hwu(The University of Texas MD Anderson Cancer Center), Elizabeth J. Shpall(The University of Texas MD Anderson Cancer Center)
Nature Reviews Clinical Oncology
September 19, 2017
Cited by 2,358Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis